Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sirolimus and Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor Hematopoietic Cell Transplantation

NCT01220297 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT01220297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01220297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sirolimus and Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor Hematopoietic Cell Transplantation
Lead sponsor
Stanford University
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2006
Completion date
August 31, 2011
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute-graft-versus-host disease, hematologic diseases, hodgkin lymphoma, leukemia, non-hodgkin lymphoma (nhl)